The New Times on MSN5h
Akagera Medicines’ TB drug shows ‘promising’ results in preclinical trials
Akagera Medicines, a Rwandan biotech company has announced promising results after completing early stages of preclinical trials of an antibiotic drug for the treatment of pulmonary tuberculosis (TB).
BlackDoctor.org10h
A Black Researcher Is Testing A Late-Stage Tuberculosis Vaccine
TB cases rise globally. New vaccine trials offer hope. Learn about TB's impact, risks, and a Dr. Alemnew Dagnew's fight for a ...
Science News14h
A new antifungal drug works in a surprising way
Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.
Open Access Government15h
University of Oxford launches first human aerosol TB vaccine trial
The University of Oxford has commenced a new clinical trial called TB-45, which will test tuberculosis (TB) vaccine safety ...
Researchers identify potential drug combinations to improve breast cancer treatment: Q&A with professor of pharmacology
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...
Healthline4d
WHO Warns of Rising Tuberculosis Cases Amid Cuts to Funding From US
The WHO reports that tuberculosis cases in children are rising globally. Experts say a rise in TB cases in Europe could mean ...
PsyPost on MSN5d
These existing medications may help reduce dementia risk, new study suggests
There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...